Please login to the form below

Not currently logged in
Email:
Password:

Pfizer calls on pharmacists in UK to promote medicine adherence

Unused medicines cost NHS England £300m per year

Pfizer Healthy Partnership (PHP) is targeting pharmacists in a new campaign to promote medicine adherence.

The campaign aims to raise awareness of the benefits of taking medicines as prescribed and will position pharmacist as 'medicines experts', who can help people understand how, when and why they should adhere to a prescription.

Posters encouraging people to seek advice from pharmacists will be displayed in pharmacies, with supporting material published across the national and regional media.

The campaign is inline with the government's plans to improve effective use of medicines, after it was estimated that unused medicines cost NHS England £300m per year.

“Through Pfizer Healthy Partnerships we provide pharmacists with a range of tools and resources aimed at helping them to support their patients in taking their medicines as prescribed, leading to an overall improvement in long term health,” said Jason Perfitt, head of pharmacy at Pfizer.

PHP has distributed information about the campaign to professional organisations and pharmacists, ahead of the launch to the general public in October.

“Not taking a medicine as prescribed means people don't receive the real benefit from it,” Martin Astbury, president of the Royal Pharmaceutical Society.

“As a result, their symptoms may not be managed effectively and their health could suffer further.

“The government has identified pharmacy as having a key role in the future of the public's health and we welcome any initiative that supports this, highlighting the important services pharmacists provide to their local communities,” Astbury said.

26th September 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics